Market News (Page 2) - TendieTensor

Market News Page 2 of 191 • 4,766 articles

Dogwood State Bank Shareholders Approve Merger into TowneBank

Benzinga • Prnewswire

Dogwood State Bank Shareholders Approve Merger into TowneBank

12/10/2025 02:45 PM • Shareholders of Dogwood State Bank have approved a merger with TowneBank, expected to close in early Q1 2026, pending regulatory approvals.

DSBX - The bank is being acquired, which suggests a strategic transition rather than a negative outcome

#merger #banking #acquisition #shareholders #regulatory approval

WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/10/2025 02:34 PM • Rosen Law Firm is investigating potential securities claims for Western Alliance Bancorporation shareholders after the company disclosed a lawsuit against a borrower, causing a stock price drop of 10.88%.

WAL - Stock price fell 10.88% after disclosing a fraud-related lawsuit against a borrower, indicating potential financial and legal challenges

#securities claims #investor losses #lawsuit #stock price drop

Hub Cyber Security Successfully Settles Legacy Class Action Litigation and Removes Structural Friction to Accelerate Execution

GlobeNewswire Inc. • Noah Hershcoviz

Hub Cyber Security Successfully Settles Legacy Class Action Litigation and Removes Structural Friction to Accelerate Execution

12/10/2025 02:32 PM • Hub Cyber Security has settled a legacy U.S. securities class action related to its 2023 IPO for $11 million, primarily financed by insurance carriers. The settlement aims to remove structural barriers and allow the company to focus on its business operations.

HUBC - The company successfully resolved a legal issue with minimal cash outlay, removed operational distractions, and positioned itself to focus on future business growth and strategic objectives

#litigation settlement #cyber security #IPO #financial restructuring

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

GlobeNewswire Inc. • Maia Biotechnology

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

12/10/2025 02:00 PM • MAIA Biotechnology is developing ateganosine, a novel telomere-targeting cancer therapy for non-small cell lung cancer patients who do not respond to existing treatments, with potential to address a significant unmet medical need.

SOUNW - Briefly mentioned as an AI software company trading at expensive valuations
MAIA - Company is developing a potentially groundbreaking first-in-class therapy targeting a large unmet medical need, with FDA Fast Track Designation and promising clinical trial progress

#telomere-targeting #non-small cell lung cancer #immunotherapy #ateganosine #oncology

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Fourth Quarter 2025 Earnings Release and Conference Call

GlobeNewswire Inc. • Tom Wirth

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Fourth Quarter 2025 Earnings Release and Conference Call

12/10/2025 01:53 PM • Brandywine Realty Trust declared a quarterly cash dividend of $0.08 per common share, payable on January 22, 2026. The company plans to release fourth quarter earnings on February 3, 2026, with a conference call scheduled for February 4, 2026.

SNOW - Briefly mentioned as an AI software company trading at expensive valuations
BDN - The announcement is a routine quarterly dividend declaration with standard financial reporting, indicating stable business operations without significant positive or negative signals

#dividend #earnings #real estate #REIT #conference call

KraneShares מחברת בין NYSE ל-ADX עם קרנות הסל האמריקאיות הראשונות שנכנסו לרשימה מוצלבת באזור

GlobeNewswire Inc. • Jonathan Krane

KraneShares מחברת בין NYSE ל-ADX עם קרנות הסל האמריקאיות הראשונות שנכנסו לרשימה מוצלבת באזור

12/10/2025 01:44 PM • KraneShares successfully cross-listed two ETFs - KWEB (China Internet) and KRBN (Global Carbon Strategy) on Abu Dhabi Securities Exchange (ADX) and NYSE, expanding global investment access and strengthening financial connections between the US, China, and Middle East markets.

KRANF - Successfully expanded global market presence by cross-listing ETFs and creating new investment opportunities

#ETF #cross-listing #global markets #carbon strategy #China internet

Portnoy Law Firm Announces Class Action on Behalf of Gauzy, Ltd. Investors

GlobeNewswire Inc. • Lesley F. Portnoy

Portnoy Law Firm Announces Class Action on Behalf of Gauzy, Ltd. Investors

12/10/2025 01:38 PM • Portnoy Law Firm is initiating a class action lawsuit against Gauzy, Ltd. for allegedly making false and misleading statements about the company's financial condition, particularly regarding three French subsidiaries' potential insolvency and debt issues.

GAUZ - The lawsuit alleges the company made materially false statements about its financial health, suggesting potential financial distress and potential insolvency of its French subsidiaries

#class action #securities #financial disclosure #investor lawsuit

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

GlobeNewswire Inc. • Delveinsight

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

12/10/2025 01:00 PM • Over 20 pharmaceutical companies are developing new treatments for celiac disease, moving beyond the current gluten-free diet management approach. Clinical trials are exploring innovative therapies targeting various mechanisms to improve patient outcomes.

NVDA - Slower growth rate compared to Palantir, but more stable with a more reasonable price-to-earnings multiple and lower investment risk
SNY - Actively developing Amlitelimab, an OX40 ligand inhibitor in Phase II clinical trials

#celiac disease #clinical trials #pharmaceutical research #autoimmune disorder #gluten sensitivity

STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process

Benzinga • Vandana Singh

STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process

12/10/2025 12:53 PM • Top investors of STAAR Surgical, including Yunqi Capital and Broadwood Partners, have rejected Alcon's revised acquisition offer of $30.75 per share, citing a flawed sale process and insufficient valuation.

STAA - Major shareholders believe the sale process is fundamentally flawed and does not maximize shareholder value

#acquisition #medical devices #go-shop period #shareholder value

CoBank releases 2026 year ahead report – forces that will shape the US rural economy

GlobeNewswire Inc. • Cobank'S Knowledge Exchange

CoBank releases 2026 year ahead report – forces that will shape the US rural economy

12/10/2025 12:47 PM • The U.S. economy is expected to remain steady in 2026, with AI investments driving GDP growth and potential market transformation, while trade policy uncertainties have decreased and tariffs are declining.

MSFT - Mentioned as a hyperscaler expanding data center infrastructure in rural areas, benefiting from AI growth

#AI #trade policy #economic outlook #tariffs #GDP growth

13-DAY JHX INVESTOR DEADLINE ALERT: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms

GlobeNewswire Inc. • Hagens Berman

13-DAY JHX INVESTOR DEADLINE ALERT: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms

12/10/2025 12:44 PM • James Hardie Industries faces a securities class action lawsuit alleging executives made false statements about North America segment sales, leading to a 34% stock drop after revealing a 12% sales decline due to customer inventory destocking.

JHX - Company allegedly misled investors about sales performance, concealed weak demand, and experienced significant stock price decline after revealing sales challenges in the North America segment

#securities lawsuit #inventory destocking #stock drop #investor claims

What's Happening With French Biotech Abivax Stock On Wednesday?

Benzinga • Vandana Singh

What's Happening With French Biotech Abivax Stock On Wednesday?

12/10/2025 12:42 PM • Abivax stock surged on market rumors of a potential takeover by Eli Lilly, following impressive clinical trial results for its ulcerative colitis treatment obefazimod.

ABVX - Stock up 1,500% in six months, positive Phase 3 trial results, potential acquisition target

#biotech #acquisition #ulcerative colitis #clinical trials #pharmaceutical

THEON signs the largest contract ever for 100,000 NVGs with OCCAR, valued at c.€1 billion

GlobeNewswire Inc. • Theon International Plc

THEON signs the largest contract ever for 100,000 NVGs with OCCAR, valued at c.€1 billion

12/10/2025 12:37 PM • THEON International Plc signed a €1 billion contract revision with OCCAR to supply 100,000 Night Vision Goggles to the German Bundeswehr and 4,000 NVGs to the Belgian Armed Forces, significantly expanding its backlog to €2.4 billion through 2029.

HAGHY - Part of the consortium winning the contract, expanding joint facility in Germany and tripling employee count

#Night Vision Goggles #Defense Contract #NATO #Military Equipment

The Hedge Fund Manager Who Called Opendoor's 10X Move Thinks This Micro-Cap Could Be the Next 100X Stock

The Motley Fool • Matt Frankel, Cfp

The Hedge Fund Manager Who Called Opendoor's 10X Move Thinks This Micro-Cap Could Be the Next 100X Stock

12/10/2025 12:35 PM • Hedge fund manager Eric Jackson highlighted Nextdoor as a potential high-growth investment, citing its 100 million verified users, low current engagement, and potential for agentic AI-driven neighborhood commerce platform.

NXDR - Jackson sees significant potential for growth, projecting $5.7 billion in high-margin revenue by decade's end and a potential $142.5 billion enterprise value

#hedge fund #micro-cap #AI #social media #investment #technology

Why GE Vernova Stock Rocketed to a 52-Week High Today

The Motley Fool • Neha Chamaria

Why GE Vernova Stock Rocketed to a 52-Week High Today

12/10/2025 12:33 PM • GE Vernova announced ambitious financial goals through 2028, doubled its dividend, increased share buyback program, and is collaborating with the U.S. government to boost rare earth supplies, leading to a significant stock price surge.

PLTR - Mentioned as a popular AI software company, but noted as trading at expensive valuations
GEV - Stock surged 15.9%, announced strong financial outlook through 2028, doubled dividend, increased share buyback, and collaborating with U.S. government on rare earth supplies

#GE Vernova #energy #turbines #dividend #rare earth #AI data centers

Small Caps Extend Record Run, GE Vernova Rallies: What's Moving Markets Wednesday?

Benzinga • Piero Cingari

Small Caps Extend Record Run, GE Vernova Rallies: What's Moving Markets Wednesday?

12/10/2025 12:30 PM • U.S. stocks edged higher ahead of the Federal Reserve's FOMC decision, with investors expecting a potential 25-basis-point rate cut. Small-cap stocks continued their record run, while GE Vernova saw significant gains and Uber faced regulatory challenges.

SOUN - Briefly mentioned as an AI software company trading at expensive valuations
GEV - Stock jumped 14% after raising its outlook during Investor Day

#Federal Reserve #FOMC #interest rates #small-cap stocks #market performance

BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

12/10/2025 12:00 PM • A class action lawsuit has been filed against Baxter International for allegedly misleading investors about systemic defects in their Novum LVP medical devices, which potentially caused patient injuries and device malfunctions.

MSFT - Third-largest ETF holding with over 13% portfolio weight and actively discussing AGI development
BAX - The lawsuit alleges serious product defects in medical devices, potential patient harm, and misleading statements to investors about product safety and performance, which would significantly damage the company's reputation and potential financial standing

#class action #securities lawsuit #medical device #investor alert

Deadline Alert: StubHub Holdings, Inc. (STUB) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: StubHub Holdings, Inc. (STUB) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/10/2025 12:00 PM • StubHub Holdings faces potential securities fraud lawsuit after IPO, with stock price dropping over 56% from initial offering price due to concerns about misleading financial reporting and vendor payment timing.

NVDA - Represents 17.16% of the ETF's weight and is a leader in GPU technology critical for AI development
STUB - Stock price declined 56% from IPO, allegations of misleading financial statements, negative free cash flow, and significant decrease in net cash provided by operating activities

#securities fraud #IPO #class action lawsuit #financial reporting

DEADLINE ALERT for AVTR, SNPS, KMX, INSP: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

GlobeNewswire Inc. • Law Offices Of Howard G. Smith

DEADLINE ALERT for AVTR, SNPS, KMX, INSP: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

12/10/2025 12:00 PM • Law firm alerts shareholders about potential securities fraud class action lawsuits for multiple companies, alleging misleading statements about business performance and prospects during specific time periods.

AVTR - Allegations of weaker competitive positioning and experiencing negative effects from increased competition

#securities fraud #class action #shareholder lawsuit #misleading statements

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/10/2025 12:00 PM • MoonLake Immunotherapeutics faces potential securities fraud lawsuit after announcing disappointing Phase 3 results for its drug candidate sonelokimab, which failed to match competitor's efficacy and caused significant stock price drop.

ZIONP - Announced a significant $50 million loan charge-off, experienced substantial stock price decline, and is facing potential legal action due to alleged misrepresentations and contractual defaults
MLTX - Stock price dropped 89.9% after revealing Phase 3 trial failure, with allegations of misleading investors about drug candidate's potential advantages

#securities fraud #class action #pharmaceutical #drug development #investor lawsuit

Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI

GlobeNewswire Inc. • Ali Kutay

Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI

12/10/2025 12:00 PM • Striim introduces Validata, a new AI-powered data validation product designed to help enterprises ensure data accuracy and trustworthiness across complex data systems, addressing critical challenges in AI and data governance.

ORCL - Mentioned as a supported data platform without specific positive or negative context

#data validation #enterprise AI #data intelligence #data governance #real-time data

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

12/10/2025 12:00 PM • A class action lawsuit has been filed against MoonLake Immunotherapeutics alleging securities fraud related to misrepresentations about their drug candidate sonelokimab, which led to significant stock value loss.

META - Announced massive $600 billion investment in US AI technology by 2028
MLTX - Stock lost nearly 90% of its value after Phase 3 trial results revealed alleged misrepresentations about drug efficacy, with lawsuit claiming false statements about drug candidate sonelokimab's performance

#class action #securities fraud #drug development #investor lawsuit

Looking For A Squeeze? Top 10 Most Shorted Stocks Right Now

Benzinga • Erica Kollmann

Looking For A Squeeze? Top 10 Most Shorted Stocks Right Now

12/10/2025 11:42 AM • Analysis reveals top 10 most shorted stocks, highlighting companies with high short interest percentages and potential for market volatility. Traders are monitoring these stocks for potential short squeeze opportunities.

IBM - Considered an AGI player but with less clear immediate potential compared to other tech companies
LCID - Highest short interest at 52.70%, indicating significant market skepticism about the company's value and future performance

#short selling #stock market #short squeeze #trading strategy

Is NuScale Power the Next Nuclear Energy Millionaire-Maker Stock?

The Motley Fool • Steven Porrello

Is NuScale Power the Next Nuclear Energy Millionaire-Maker Stock?

12/10/2025 11:31 AM • NuScale Power, a small modular reactor (SMR) company, has received regulatory approval for its reactor design but faces challenges in turning designs into actual construction and proving cost-competitiveness with other energy generation methods.

SMR - The company has potential but needs to overcome significant challenges like securing firm orders, proving cost-effectiveness, and scaling operations. While it has a regulatory-approved design, it has not yet built an actual reactor.

#nuclear energy #small modular reactors #SMR #energy sector #electricity generation

Technology Implementation Now a Top Challenge for Real Estate Leaders, NAA Research in Partnership with AppFolio Finds

GlobeNewswire Inc. • Appfolio And National Apartment Association (Naa)

Technology Implementation Now a Top Challenge for Real Estate Leaders, NAA Research in Partnership with AppFolio Finds

12/10/2025 11:00 AM • A survey of nearly 2,000 real estate professionals reveals technology implementation is now a top challenge, with leaders spending most time on routine operational work instead of strategic activities. AI adoption is widespread but its full potential remains untapped.

GOOG - Entered billion-dollar deal with Apple to power Siri, maintaining existing business relationship
APPF - Positioned as a technology leader offering solutions to industry challenges, presenting their platform as a way to help property managers improve operational efficiency and strategic focus

#real estate #technology #AI #performance management #property management